We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGRY icon
551
Surgery Partners
SGRY
$2.04B
$2.64M 0.01%
62,398
+237
+0.4% +$12.1K
SUM
552
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$2.59M 0.01%
82,505
+16,487
+25% +$538K
MAQCU
553
DELISTED
Maquia Capital Acquisition Corporation Unit
MAQCU
$2.56M 0.01%
250,000
EOCW.U
554
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
$2.53M 0.01%
250,000
ROCGU
555
DELISTED
Roth CH Acquisition IV Co. Unit
ROCGU
$2.52M 0.01%
+250,000
New +$2.51M
CRZNU
556
DELISTED
Corazon Capital V838 Monoceros Corp Unit
CRZNU
$2.5M 0.01%
250,000
IBER.U
557
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
$2.5M 0.01%
250,000
PRBM.U
558
DELISTED
Parabellum Acquisition Corp. Units, each consisting of one share of Class A common stock and three-quarters of one redeemable warrant
PRBM.U
$2.49M 0.01%
+250,000
New +$2.49M
GGMCU
559
DELISTED
Glenfarne Merger Corp. Unit
GGMCU
$2.49M 0.01%
250,000
PMGMU
560
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$2.48M 0.01%
250,000
TWNI.U
561
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
$2.48M 0.01%
250,000
TRCA.U
562
DELISTED
Twin Ridge Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TRCA.U
$2.47M 0.01%
250,000
PSAGU
563
DELISTED
Property Solutions Acquisition Corporation II Units
PSAGU
$2.46M 0.01%
250,000
KRNL
564
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$2.44M 0.01%
250,000
RCLFU
565
DELISTED
Rosecliff Acquisition Corp I Unit
RCLFU
$2.42M 0.01%
244,578
+34,926
+17% +$346K
KDMN
566
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.4M 0.01%
+276,111
New +$1.57M
RNG icon
567
RingCentral
RNG
$4.77B
$2.4M 0.01%
11,042
+199
+2% +$50.5K
NET icon
568
Cloudflare
NET
$93.7B
$2.4M 0.01%
21,280
ACAHU
569
DELISTED
Atlantic Coastal Acquisition Corp. Unit
ACAHU
$2.37M 0.01%
240,000
LSPD icon
570
Lightspeed Commerce
LSPD
$1.41B
$2.31M 0.01%
23,986
+12,197
+103% +$1.21M
ONEW icon
571
OneWater Marine
ONEW
$217M
$2.29M 0.01%
56,829
-19,785
-26% -$830K
MMP
572
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.26M 0.01%
49,660
RYM
573
RYTHM Inc
RYM
$41.4M
$2.26M 0.01%
41
+30
+273% +$1.97M
NGCAU
574
DELISTED
NextGen Acquisition Corp. II Units
NGCAU
$2.24M 0.01%
217,734
-121,649
-36% -$1.25M
CDNA icon
575
CareDx
CDNA
$1.85B
$2.23M 0.01%
35,134
-40,634
-54% -$3.09M

Similar funds

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.